PTEN and prostate neoplasm: Cell survival pathways, such as the TLR/IL1-R/NF-κB, PTEN/PI3K/AKT/mTOR, and RAS/MAPK pathways, are important players in the maintenance of PCSCs and their progenitors in castration-resistant prostate tumors [252,253,254].